Viral hepatitis: Human genes that limit infection

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 5, 2010, Pages 709-723

  Grünhage, Frank ^a   Nattermann, Jacob ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Chronic hepatitis B; Chronic hepatitis C; Genetic susceptibility factors

Indexed keywords

ALPHA INTERFERON; APOLIPOPROTEIN E; ARGONAUTE 1 PROTEIN; CHEMOKINE RECEPTOR CCR5; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; I KAPPA B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 29; INTERLEUKIN 6; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MYXOVIRUS RESISTANCE PROTEIN; OSTEOPONTIN; PEGINTERFERON; RANTES; RIBAVIRIN; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR 7; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANEMIA; ANTIVIRAL ACTIVITY; APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; CHEMOTAXIS; CYTOKINE RELEASE; ETHNICITY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS C; HEREDITY; HETEROZYGOTE; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFECTION CONTROL; LEUKOPENIA; MENTAL DISEASE; MONOTHERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS HEPATITIS;

EID: 77958108031     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.07.009     Document Type: Article

References (110)

1. D. Ge, J. Fellay, and A.J. Thompson Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
2. McCarthy JJ, Li JH, Thompson A, et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology.
3. Rauch A, Kutalik Z, Descombes P, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology.
4. V. Suppiah, M. Moldovan, and G. Ahlenstiel IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
5. Y. Tanaka, N. Nishida, and M. Sugiyama Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
6. D.L. Thomas, C.L. Thio, and M.P. Martin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
7. S.V. Kotenko, G. Gallagher, and V.V. Baurin IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex Nat Immunol 4 2003 69 77
8. P. Sheppard, W. Kindsvogel, and W. Xu IL-28, IL-29 and their class II cytokine receptor IL-28R Nat Immunol 4 2003 63 68 Epub 2002 Dec 2
9. T. Marcello, A. Grakoui, and G. Barba-Spaeth Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics Gastroenterology 131 2006 1887 1898
10. G. Ramadori, and B. Christ Cytokines and the hepatic acute-phase response Semin Liver Dis 19 1999 141 155
11. Gao B. Cytokines STATs and liver disease Cell Mol Immunol 2 2005 92 100
12. D. Fishman, G. Faulds, and R. Jeffery The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1998 1369 1376
13. S. Barrett, M. Collins, and C. Kenny Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection J Med Virol 71 2003 212 218
14. E.J. Minton, D. Smillie, and P. Smith Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes Hum Immunol 66 2005 127 132
15. D. Lio, C. Caruso, and R. Di Stefano IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection Hum Immunol 64 2003 674 680
16. N. Paladino, H. Fainboim, and G. Theiler Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism J Virol 80 2006 9144 9150
17. T.K. Oleksyk, C.L. Thio, and A.L. Truelove Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance Genes Immun 6 2005 347 357
18. K. Kusumoto, H. Uto, and K. Hayashi Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan Cytokine 34 2006 24 31
19. A. Mangia, R. Santoro, and M. Piattelli IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection Cytokine 25 2004 103 109
20. J.Y. Cheong, S.W. Cho, and I.L. Hwang Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms J Gastroenterol Hepatol 21 2006 1163 1169
21. A.J. Frodsham, L. Zhang, and U. Dumpis Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence Proc Natl Acad Sci USA 103 2006 9148 9153
22. A. Houldsworth, M. Metzner, and S. Rossol Polymorphisms in the IL-12B gene and outcome of HCV infection J Interferon Cytokine Res. 25 2005 271 276
23. T. Mueller, A. Mas-Marques, and C. Sarrazin Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection J Hepatol 41 2004 652 658
24. L.M. Yin, W.F. Zhu, and L. Wei Association of interleukin-12 p40 gene 3′-untranslated region polymorphism and outcome of HCV infection World J Gastroenterol 10 2004 2330 2333
25. P. An, C.L. Thio, and G.D. Kirk Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance J Infect Dis 198 2008 1159 1165
26. B.J. Hennig, A.J. Frodsham, and S. Hellier Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection Liver Int 27 2007 1134 1143
27. T. Kimura, T. Saito, and M. Yoshimura Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus J Infect Dis 193 2006 1371 1374
28. E. Larrea, N. Garcia, and C. Qian Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C Hepatology 23 1996 210 217
29. S. D'Alfonso, and P.M. Richiardi A polymorphic variation in a putative regulation box of the TNFA promoter region Immunogenetics 39 1994 150 154
30. A.G. Wilson, N. de Vries, and F. Pociot An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles J Exp Med 177 1993 557 560
31. A.G. Wilson, J.A. Symons, and T.L. McDowell Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Natl Acad Sci U S A 94 1997 3195 3199
32. T. Hohler, A. Kruger, and G. Gerken A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection Clin Exp Immunol 111 1998 579 582 (Pubitemid 28160904)
33. C.Y. Dai, W.L. Chuang, and W.Y. Chang Tumor necrosis factor-alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection J Infect Dis 193 2006 98 101
34. L.J. Yee, J. Tang, and J. Herrera Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection Genes Immun 1 2000 386 390
35. U. Schiemann, J. Glas, and P. Torok Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism Digestion 68 2003 1 4
36. Y.J. Kim, H.S. Lee, and J.H. Yoon Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection Hum Mol Genet. 12 2003 2541 2546
37. G.A. Niro, R. Fontana, and D. Gioffreda Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection Liver Int 25 2005 1175 1181
38. T. Du, X.H. Guo, and X.L. Zhu Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population J Viral Hepat 13 2006 618 624
39. M.H. Somi, L. Najafi, and B.N. Noori Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B Indian J Gastroenterol 25 2006 14 15
40. J.H. Bream, M. Carrington, and S. O'Toole Polymorphisms of the human IFNG gene noncoding regions Immunogenetics 51 2000 50 58
41. V. Pravica, A. Asderakis, and C. Perrey In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene Eur J Immunogenet 26 1999 1 3
42. Y. Huang, H. Yang, and B.B. Borg A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection Proc Natl Acad Sci U S A 104 2007 985 990
43. M. Liu, B. Cao, and H. Zhang Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection Immunogenetics 58 2006 859 864
44. S.H. Ahn, Y. Kim do, and H.Y. Chang Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea J Med Virol 78 2006 1564 1571
45. H.Y. Chang, S.H. Ahn, and D.Y. Kim [Association between CCR5 promoter polymorphisms and hepatitis B virus infection] Korean J Hepatol 11 2005 116 124
46. C. Neumann-Haefelin, H.E. Blum, and F.V. Chisari T cell response in hepatitis C virus infection J Clin Virol 32 2005 75 85
47. R. Singh, R. Kaul, and A. Kaul A comparative review of HLA associations with hepatitis B and C viral infections across global populations World J Gastroenterol 13 2007 1770 1787
48. L. Alric, M. Fort, and J. Izopet Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance Tissue Antigens 56 2000 154 158
49. M. Thursz, R. Yallop, and R. Goldin Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research Lancet 354 1999 2119 2124
50. S.M. McKiernan, R. Hagan, and M. Curry Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source Hepatology 40 2004 108 114
51. W.C. Chuang, F. Sarkodie, and C.J. Brown Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population J Med Virol 79 2007 724 733
52. C.L. Thio, X. Gao, and J.J. Goedert HLA-Cw*04 and hepatitis C virus persistence J Virol 76 2002 4792 4797
53. P. Hraber, C. Kuiken, and K. Yusim Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection Hepatology 46 2007 1713 1721
54. X. Hong, R.B. Yu, and N.X. Sun Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis World J Gastroenterol 11 2005 7302 7307
55. P. Kummee, P. Tangkijvanich, and Y. Poovorawan Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population J Viral Hepat 14 2007 841 848
56. M.R. Thursz, D. Kwiatkowski, and C.E. Allsopp Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia N Engl J Med 332 1995 1065 1069
57. H.M. Diepolder, M.C. Jung, and E. Keller A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B Clin Exp Immunol 113 1998 244 251
58. S.I. Khakoo, C.L. Thio, and M.P. Martin HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 305 2004 872 874
59. S. Knapp, U. Warshow, and D. Hegazy Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus Hepatology 2009
60. Z. Lu, B. Zhang, and S. Chen Association of KIR genotypes and haplotypes with susceptibility to chronic hepatitis B virus infection in Chinese Han population Cell Mol Immunol 5 2008 457 463
61. J. Zuniga, V. Romero, and J. Azocar Protective KIR-HLA interactions for HCV infection in intravenous drug users Mol Immunol 46 2009 2723 2727
62. C.M. Gardiner Killer cell immunoglobulin-like receptors on NK cells: the how, where and why Int J Immunogenet 35 2008 1 8
63. L. Zhi-ming, J. Yu-lian, and F. Zhao-lei Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population Croat Med J 48 2007 800 806
64. Z. Jiang, X. Feng, and W. Zhang Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients Liver Int 27 2007 1202 1208
65. C.L. Thio, T.L. Mosbruger, and R.A. Kaslow Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection J Virol 78 2004 11258 11262
66. C. Zhu, R. Zhang, and D. Liu Association of functional polymorphism of ApoB promoter with hepatitis C virus infection Clin Chim Acta 401 2009 124 127
67. H.D. Shin, B.L. Park, and H.S. Cheong SPP1 polymorphisms associated with HBV clearance and HCC occurrence Int J Epidemiol 36 2007 1001 1008
68. B.L. Park, Y.J. Kim, and H.S. Cheong Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance Exp Mol Med 38 2006 694 702
69. J.Y. Cheong, S.W. Cho, and J.Y. Choi RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population J Korean Med Sci. 22 2007 529 535
70. J.Y. Cheong, S.W. Cho, and S.G. Chung Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection Biochem Genet 44 2006 246 255
71. J. Zhou, D.Q. Chen, and V.K. Poon A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection Immunogenetics 61 2009 423 430
72. Y.J. Kim, J.H. Yoon, and C.Y. Kim IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma Biochem Biophys Res Commun 346 2006 38 44
73. C. Sarrazin, T. Berg, and R.S. Ross Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection Z Gastroenterol 48 2010 289 351
74. T.M. Welzel, T.R. Morgan, and H.L. Bonkovsky Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial Hepatology 49 2009 1847 1858
75. X. Su, L.J. Yee, and K. Im Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C J Hepatol 49 2008 184 191
76. M. Hijikata, Y. Ohta, and S. Mishiro Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon Intervirology 43 2000 124 127
77. S. Knapp, L.J. Yee, and A.J. Frodsham Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR Genes Immun 4 2003 411 419
78. F. Suzuki, Y. Arase, and Y. Suzuki Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection J Viral Hepat 11 2004 271 276
79. M. Persico, M. Capasso, and R. Russo Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C Gut 57 2008 507 515
80. M. Lindemann, S. Virchow, and F. Ramann The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response FEBS Lett 495 2001 82 86
81. C. Sarrazin, T. Berg, and V. Weich GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection J Hepatol 43 2005 388 393
82. G. Ahlenstiel, H.D. Nischalke, and K. Bueren The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients J Hepatol 47 2007 348 355
83. P.K. Constantini, M. Wawrzynowicz-Syczewska, and M. Clare Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy Liver 22 2002 404 412
84. C.J. Edwards-Smith, J.R. Jonsson, and D.M. Purdie Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa Hepatology 30 1999 526 530
85. P.G. Vidigal, J.J. Germer, and N.N. Zein Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin J Hepatol 36 2002 271 277
86. J.A. Gracie, S.E. Robertson, and I.B. McInnes Interleukin-18 J Leukoc Biol 73 2003 213 224
87. K. Nakanishi, T. Yoshimoto, and H. Tsutsui Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu Cytokine Growth Factor Rev. 12 2001 53 72
88. H. Tsutsui, K. Adachi, and E. Seki Cytokine-induced inflammatory liver injuries Curr Mol Med 3 2003 545 559
89. S.L. Haas, C. Weiss, and P. Bugert Interleukin 18 promoter variants (-137G>C and -607C>A) in patients with chronic hepatitis C: association with treatment response J Clin Immunol 29 2009 620 628
90. V. Giedraitis, B. He, and W.X. Huang Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation J Neuroimmunol 112 2001 146 152
91. M.G. Neuman, J.P. Benhamou, and M. Martinot Predictors of sustained response to alpha interferon therapy in chronic hepatitis C Clin Biochem 32 1999 537 545
92. H.R. Rosen, J.G. McHutchison, and A.J. Conrad Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C Am J Gastroenterol 97 2002 714 720
93. H.E. Wasmuth, A. Werth, and T. Mueller Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C Hepatology 40 2004 327 334
94. A. Almarri, N. El Dwick, and S. Al Kabi Interferon-alpha therapy in HCV hepatitis: HLA phenotype and cirrhosis are independent predictors of clinical outcome Hum Immunol 59 1998 239 242
95. J. Jiao, and J.B. Wang Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-alpha and ribavirin in patients with chronic hepatitis C Hepatobiliary Pancreat Dis Int 4 2005 80 83
96. M. Romero-Gomez, M.F. Gonzalez-Escribano, and B. Torres HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C Am J Gastroenterol 98 2003 1621 1626
97. E. Schott, H. Witt, and K. Neumann Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy J Viral Hepat 15 2008 71 78
98. P. Lebray, H. Zylberberg, and S. Hue Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C J Viral Hepat 11 2004 175 182
99. L.J. Yee, K.A. Perez, and J. Tang Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection J Infect Dis 187 2003 1264 1271
100. J. Fellay, A.J. Thompson, and D. Ge ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C Nature 464 2010 405 408
101. M. Wada, H. Marusawa, and R. Yamada Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients J Viral Hepat 16 2009 388 396
102. P.A. Gochee, E.E. Powell, and D.M. Purdie Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C Psychosomatics 45 2004 49 57
103. K. Horsburgh, M.O. McCarron, and F. White The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models Neurobiol Aging 21 2000 245 255
104. Q.M. Gong, X.F. Kong, and Z.T. Yang Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection J Viral Hepat 16 2009 674 680
105. H.L. Chan, A.M. Tse, and M.D. Zhang Genetic polymorphisms of interleukin-1-beta in association with sustained response to anti-viral treatment in chronic hepatitis B in Chinese Aliment Pharmacol Ther 23 2006 1703 1711
106. X. Wu, X. Zhu, and S. Zhu A pharmacogenetic study of polymorphisms in interferon pathway genes and response to interferon-alpha treatment in chronic hepatitis B patients Antiviral Res 83 2009 252 256
107. Y.X. Huang, L.N. Ma, and X.Y. Chen Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B Zhonghua Gan Zang Bing Za Zhi 15 2007 187 191
108. J.K. King, S.H. Yeh, and M.W. Lin Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: a pilot study Hepatology 36 2002 1416 1424
109. Y.K. Park, J.M. Lee, and D.Y. Kim Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B Dig Dis Sci 2009
110. E. Schott, H. Witt, and H. Hinrichsen Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection J Hepatol 46 2007 372 380